Re: Berg et al.: Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol (Ophthalmology 2015;122:146-52).

Authors	Robert L Avery
Journal	Ophthalmology (Ophthalmology) Vol. 123 Issue 2 Pg. e14-e16 (Feb 2016) ISSN: 1549-4713 [Electronic] United States
PMID	26802717 (Publication Type: Letter, Comment)
Chemical References	Angiogenesis Inhibitors Antibodies, Monoclonal, Humanized
Topics	Angiogenesis Inhibitors (therapeutic use) Antibodies, Monoclonal, Humanized (therapeutic use) Female Humans Male Wet Macular Degeneration (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!